HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 958 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 956.00 shares.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 2.00 shares.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 2.69K shares, a 92.83% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 542.09K shares, a 1966.36% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 663.45K shares, a 699.11% increase from fiscal 2024.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 83.02K shares, a 17.85% decline from fiscal 2023.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 101.06K shares, a 19.64% decline from fiscal 2022.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 125.77K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 956.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 958.00 shares 10-Q · filed 2026-08-11 | 3.65K shares derived: sum of 3 quarters · filed 2026-08-11 | 545.74K shares derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | 2.00 shares 10-Q · filed 2026-05-12 | 2.69K shares derived: sum of 2 quarters · filed 2026-05-12 | 544.78K shares derived: sum of 3 quarters · filed 2026-05-12 | ||
| 2025-12-31 | 2.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 544.78K shares derived: sum of 2 quarters · filed 2026-03-13 | 663.45K shares 10-K · filed 2026-03-13 | ||
| 2025-09-30 | 542.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 660.75K shares 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 118.67K shares 10-Q · filed 2025-08-11 | ||||
| 2024-12-31 | 37.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 63.76K shares derived: sum of 2 quarters · filed 2026-03-13 | 83.02K shares 10-K · filed 2026-03-13 | ||
| 2024-09-30 | 26.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | 45.50K shares 10-Q · filed 2025-05-12 | 23.77K shares 10-Q · filed 2024-11-08 | ||
| 2024-06-30 | 19.27K shares 10-Q · filed 2024-08-08 | ||||
| 2023-12-31 | 101.06K shares 10-K · filed 2025-03-14 | ||||
| 2022-12-31 | 125.77K shares 10-K · filed 2024-03-07 | ||||
| 2020-09-30 | 20.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 253.42K shares 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | 233.08K shares 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |